Jennifer Baxter

Highlighting what industry will need to do differently to achieve an ambitious future where all patients can receive lifesaving medicines safely, swiftly, reliably, and affordably Providing a glimpse of how the world will evolve as molecular complexity increases in the future for small molecules, blurring the boundaries between small and large molecules Exploring the role that new technologies will play in achieving that transformation — Jennifer Baxter VP, Small Molecule Science and Technology Merck Jennifer Baxter has over 20 years of experience in pharmaceutical development and manufacturing activities. During her tenure at Merck, Jennifer has worked in research & development,…